Shukun Technology

Shukun Technology is an AI medical imaging company that focuses on developing diagnostics systems for chronic diseases.

Shukun Technology develops diagnostic systems by using machine learning and AI technology for hospitals to improve efficiency.

Shukun Technology was founded in 2017 by Annne Ma. The company is headquartered in Beijing, Beijing, China.

 

Shukun is the world's first AI imaging diagnosis platform covering heart, nerves, and tumors. It provides heart disease, stroke, Intelligent diagnosis and treatment plan for critical diseases such as cancer.

 

Shukun AI medical imaging diagnosis platform has covered Peking Union Medical College Hospital, Beijing Anzhen Hospital Affiliated to Capital Medical University, Beijing Friendship Hospital Affiliated to Capital Medical University, Xuanwu Hospital of Capital Medical University, First Affiliated Hospital of Zhengzhou University, Ruijin Affiliated to Shanghai Jiaotong University School of Medicine Hospital etc.

 

Shukun, relying on its own powerful artificial intelligence scientific research platform and cloud platform, collaborates with scientific research institutions and medical institutions to realize the intelligent Internet medical model of human-computer collaboration, and develop big data artificial intelligence cross-regional, interdisciplinary, and multi-center clinical Scientific research.

 

Shukun is backed by Chuangshi Partners Capital, Yuanyi Capital, Huagai Capital, Morningside Capital, Qiming Venture Partners, BOC International, Jianxing Medical Fund, China Creation Ventures and others. The company raised $28.25M in Series B2 round on Aug 31, 2020, brining the Series B total to $56.5M. The latest financing also brings Shukun's total funding to $105.3M to date.

 

 

  • Year founded: 2017
  • Funding Info: $105.3M over 4 Rounds (Latest Funding Type: Series B)
  • Yearly Revenue: NA
  • Employee Size: 51-200
  • Business Valuation: NA
  • City/Town: Beijing
  • State: Beijing
  • Country: China
Related businesses